Source: Clinics. Unidades: FMRP, FCFRP
Subjects: HEPATOPATIAS, OSTEOPOROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPIRLANDELI, Adriano Levi et al. Hepatic osteodystrophy: the mechanism of bone loss in hepatocellular disease and the effects of pamidronate treatment. Clinics, v. 72, n. 4, p. 231-237, 2017Tradução . . Disponível em: https://doi.org/10.6061/clinics/2017(04)07. Acesso em: 01 nov. 2024.APA
Spirlandeli, A. L., Dick-de-Paula, I., Zamarioli, A., Jorgetti, V., Ramalho, L. N. Z., Nogueira-Barbosa, M. H., et al. (2017). Hepatic osteodystrophy: the mechanism of bone loss in hepatocellular disease and the effects of pamidronate treatment. Clinics, 72( 4), 231-237. doi:10.6061/clinics/2017(04)07NLM
Spirlandeli AL, Dick-de-Paula I, Zamarioli A, Jorgetti V, Ramalho LNZ, Nogueira-Barbosa MH, Volpon JB, Jordão Júnior AA, Cunha F de Q, Fukada SY, Paula FJA de. Hepatic osteodystrophy: the mechanism of bone loss in hepatocellular disease and the effects of pamidronate treatment [Internet]. Clinics. 2017 ; 72( 4): 231-237.[citado 2024 nov. 01 ] Available from: https://doi.org/10.6061/clinics/2017(04)07Vancouver
Spirlandeli AL, Dick-de-Paula I, Zamarioli A, Jorgetti V, Ramalho LNZ, Nogueira-Barbosa MH, Volpon JB, Jordão Júnior AA, Cunha F de Q, Fukada SY, Paula FJA de. Hepatic osteodystrophy: the mechanism of bone loss in hepatocellular disease and the effects of pamidronate treatment [Internet]. Clinics. 2017 ; 72( 4): 231-237.[citado 2024 nov. 01 ] Available from: https://doi.org/10.6061/clinics/2017(04)07
